1. Home
  2. RXST vs SENS Comparison

RXST vs SENS Comparison

Compare RXST & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RxSight Inc.

RXST

RxSight Inc.

HOLD

Current Price

$4.62

Market Cap

300.5M

Sector

Health Care

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$6.63

Market Cap

301.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXST
SENS
Founded
1997
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
300.5M
301.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
RXST
SENS
Price
$4.62
$6.63
Analyst Decision
Hold
Strong Buy
Analyst Count
10
4
Target Price
$9.78
$18.38
AVG Volume (30 Days)
893.3K
495.3K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$134,479,000.00
$16,389,000.00
Revenue This Year
N/A
$74.15
Revenue Next Year
$10.06
$58.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.85
52 Week Low
$4.48
$0.41
52 Week High
$14.22
$8.75

Technical Indicators

Market Signals
Indicator
RXST
SENS
Relative Strength Index (RSI) 33.74 48.64
Support Level $4.48 $6.40
Resistance Level $7.60 $6.87
Average True Range (ATR) 0.28 0.49
MACD 0.01 -0.04
Stochastic Oscillator 16.91 15.67

Price Performance

Historical Comparison
RXST
SENS

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: